Insider · CIK 0001609492
MPM BioVentures 2014, L.P.
Files at: TRDA, TCRR, HARP. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 9, 7:23 pm EDT | Entrada Therapeutics, Inc.TRDA | 259,837 | $7.33 | $1,905,768 | 3,885,115 | −6.27% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 7:21 pm EDT | Entrada Therapeutics, Inc.TRDA | 86,482 | $7.14 | $617,379 | 4,144,952 | −2.04% | |
| Aug 27, 2026 SForm 4 → | Aug 31, 6:25 pm EDT | Entrada Therapeutics, Inc.TRDA | 86,914 | $7.08 | $615,777 | 4,231,434 | −2.01% | |
| Aug 24, 2026 SForm 4 → | Aug 26, 9:28 pm EDT | Entrada Therapeutics, Inc.TRDA | 62,714 | $7.36 | $461,546 | 4,318,348 | −1.43% | |
| Feb 19, 2019 PForm 4 → | Feb 21, 6:05 pm EST | TCR2 THERAPEUTICS INC.TCRR | 706,666 | $15.00 | $10,599,990 | 4,050,865 | +21.1% | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 6:05 pm EST | TCR2 THERAPEUTICS INC.TCRR | 3,148,297 | — | — | 3,344,199 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:32 pm EST | Harpoon Therapeutics, Inc.HARP | 250,000 | $14.00 | $3,500,000 | 4,524,425 | +5.85% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 5:32 pm EST | Harpoon Therapeutics, Inc.HARP | 1,524 | $14.00 | $21,336 | 4,274,425 | −0.04% | plan? |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:32 pm EST | Harpoon Therapeutics, Inc.HARP | 3,953,886 | $0.0492 | $21,260 | 4,275,949 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2019 CForm 4 → | Feb 21, 6:05 pm EST | TCR2 THERAPEUTICS INC.TCRR | 19,500,000 | — | — | 0 | — | |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:32 pm EST | Harpoon Therapeutics, Inc.HARP | 3,953,886 | — | — | 0 | — |